Logo image of 1EL.MI

ESSILORLUXOTTICA (1EL.MI) Stock Fundamental Analysis

Europe - BIT:1EL - FR0000121667 - Common Stock

316.9 EUR
-0.9 (-0.28%)
Last: 11/3/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, 1EL scores 4 out of 10 in our fundamental rating. 1EL was compared to 60 industry peers in the Health Care Equipment & Supplies industry. 1EL has a medium profitability rating, but doesn't score so well on its financial health evaluation. 1EL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year 1EL was profitable.
In the past year 1EL had a positive cash flow from operations.
In the past 5 years 1EL has always been profitable.
Each year in the past 5 years 1EL had a positive operating cash flow.
1EL.MI Yearly Net Income VS EBIT VS OCF VS FCF1EL.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

1EL has a Return On Assets (3.84%) which is in line with its industry peers.
1EL has a Return On Equity of 6.29%. This is comparable to the rest of the industry: 1EL outperforms 50.00% of its industry peers.
1EL has a Return On Invested Capital (5.39%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for 1EL is below the industry average of 9.00%.
The last Return On Invested Capital (5.39%) for 1EL is above the 3 year average (4.84%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.84%
ROE 6.29%
ROIC 5.39%
ROA(3y)3.67%
ROA(5y)2.72%
ROE(3y)5.86%
ROE(5y)4.39%
ROIC(3y)4.84%
ROIC(5y)3.74%
1EL.MI Yearly ROA, ROE, ROIC1EL.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

1EL has a Profit Margin of 8.74%. This is in the better half of the industry: 1EL outperforms 61.67% of its industry peers.
In the last couple of years the Profit Margin of 1EL has grown nicely.
1EL's Operating Margin of 12.86% is fine compared to the rest of the industry. 1EL outperforms 61.67% of its industry peers.
In the last couple of years the Operating Margin of 1EL has grown nicely.
With a decent Gross Margin value of 61.91%, 1EL is doing good in the industry, outperforming 65.00% of the companies in the same industry.
1EL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.86%
PM (TTM) 8.74%
GM 61.91%
OM growth 3Y4.69%
OM growth 5Y6.47%
PM growth 3Y6.8%
PM growth 5Y7.52%
GM growth 3Y0.88%
GM growth 5Y0.39%
1EL.MI Yearly Profit, Operating, Gross Margins1EL.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1EL is destroying value.
Compared to 1 year ago, 1EL has more shares outstanding
The number of shares outstanding for 1EL has been increased compared to 5 years ago.
1EL has a worse debt/assets ratio than last year.
1EL.MI Yearly Shares Outstanding1EL.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
1EL.MI Yearly Total Debt VS Total Assets1EL.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

1EL has an Altman-Z score of 4.62. This indicates that 1EL is financially healthy and has little risk of bankruptcy at the moment.
1EL has a Altman-Z score of 4.62. This is in the better half of the industry: 1EL outperforms 78.33% of its industry peers.
1EL has a debt to FCF ratio of 4.18. This is a neutral value as 1EL would need 4.18 years to pay back of all of its debts.
1EL has a Debt to FCF ratio of 4.18. This is in the better half of the industry: 1EL outperforms 66.67% of its industry peers.
1EL has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
1EL has a Debt to Equity ratio (0.25) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 4.18
Altman-Z 4.62
ROIC/WACC0.69
WACC7.82%
1EL.MI Yearly LT Debt VS Equity VS FCF1EL.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

1EL has a Current Ratio of 0.97. This is a bad value and indicates that 1EL is not financially healthy enough and could expect problems in meeting its short term obligations.
1EL has a Current ratio of 0.97. This is amonst the worse of the industry: 1EL underperforms 80.00% of its industry peers.
A Quick Ratio of 0.67 indicates that 1EL may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.67, 1EL is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.67
1EL.MI Yearly Current Assets VS Current Liabilites1EL.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

1EL shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.00%.
The Earnings Per Share has been growing by 16.01% on average over the past years. This is quite good.
1EL shows a small growth in Revenue. In the last year, the Revenue has grown by 5.45%.
Measured over the past years, 1EL shows a quite strong growth in Revenue. The Revenue has been growing by 8.80% on average per year.
EPS 1Y (TTM)3%
EPS 3Y13.7%
EPS 5Y16.01%
EPS Q2Q%2.1%
Revenue 1Y (TTM)5.45%
Revenue growth 3Y10.18%
Revenue growth 5Y8.8%
Sales Q2Q%5.52%

3.2 Future

Based on estimates for the next years, 1EL will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.20% on average per year.
The Revenue is expected to grow by 6.39% on average over the next years.
EPS Next Y6.78%
EPS Next 2Y8.91%
EPS Next 3Y9.98%
EPS Next 5Y9.2%
Revenue Next Year4.62%
Revenue Next 2Y5.36%
Revenue Next 3Y5.93%
Revenue Next 5Y6.39%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1EL.MI Yearly Revenue VS Estimates1EL.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B
1EL.MI Yearly EPS VS Estimates1EL.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

1EL is valuated quite expensively with a Price/Earnings ratio of 46.13.
Compared to the rest of the industry, the Price/Earnings ratio of 1EL is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.03, 1EL is valued quite expensively.
With a Price/Forward Earnings ratio of 39.35, 1EL can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, 1EL is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.27, 1EL is valued quite expensively.
Industry RankSector Rank
PE 46.13
Fwd PE 39.35
1EL.MI Price Earnings VS Forward Price Earnings1EL.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1EL.
The rest of the industry has a similar Price/Free Cash Flow ratio as 1EL.
Industry RankSector Rank
P/FCF 43.64
EV/EBITDA 23.78
1EL.MI Per share data1EL.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of 1EL may justify a higher PE ratio.
PEG (NY)6.81
PEG (5Y)2.88
EPS Next 2Y8.91%
EPS Next 3Y9.98%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.24%, 1EL has a reasonable but not impressive dividend return.
1EL's Dividend Yield is a higher than the industry average which is at 2.13.
Compared to an average S&P500 Dividend Yield of 2.38, 1EL's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.24%

5.2 History

The dividend of 1EL has a limited annual growth rate of 4.50%.
Dividend Growth(5Y)4.5%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

22.97% of the earnings are spent on dividend by 1EL. This is a low number and sustainable payout ratio.
The dividend of 1EL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP22.97%
EPS Next 2Y8.91%
EPS Next 3Y9.98%
1EL.MI Yearly Income VS Free CF VS Dividend1EL.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
1EL.MI Dividend Payout.1EL.MI Dividend Payout, showing the Payout Ratio.1EL.MI Dividend Payout.PayoutRetained Earnings

ESSILORLUXOTTICA

BIT:1EL (11/3/2025, 7:00:00 PM)

316.9

-0.9 (-0.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-16 2025-10-16
Earnings (Next)02-03 2026-02-03/amc
Inst Owners29.19%
Inst Owner ChangeN/A
Ins Owners32.47%
Ins Owner ChangeN/A
Market Cap146.77B
Revenue(TTM)27.24B
Net Income(TTM)2.38B
Analysts78.67
Price Target314.87 (-0.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.24%
Yearly Dividend2.56
Dividend Growth(5Y)4.5%
DP22.97%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.75%
PT rev (3m)14.07%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-9.81%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.53%
Valuation
Industry RankSector Rank
PE 46.13
Fwd PE 39.35
P/S 5.39
P/FCF 43.64
P/OCF 29.87
P/B 3.88
P/tB N/A
EV/EBITDA 23.78
EPS(TTM)6.87
EY2.17%
EPS(NY)8.05
Fwd EY2.54%
FCF(TTM)7.26
FCFY2.29%
OCF(TTM)10.61
OCFY3.35%
SpS58.82
BVpS81.67
TBVpS-5.08
PEG (NY)6.81
PEG (5Y)2.88
Graham Number112.36
Profitability
Industry RankSector Rank
ROA 3.84%
ROE 6.29%
ROCE 6.93%
ROIC 5.39%
ROICexc 5.71%
ROICexgc 35.85%
OM 12.86%
PM (TTM) 8.74%
GM 61.91%
FCFM 12.34%
ROA(3y)3.67%
ROA(5y)2.72%
ROE(3y)5.86%
ROE(5y)4.39%
ROIC(3y)4.84%
ROIC(5y)3.74%
ROICexc(3y)5.06%
ROICexc(5y)3.96%
ROICexgc(3y)34.05%
ROICexgc(5y)28.3%
ROCE(3y)6.22%
ROCE(5y)4.81%
ROICexgc growth 3Y0.01%
ROICexgc growth 5Y9.27%
ROICexc growth 3Y12.06%
ROICexc growth 5Y11.05%
OM growth 3Y4.69%
OM growth 5Y6.47%
PM growth 3Y6.8%
PM growth 5Y7.52%
GM growth 3Y0.88%
GM growth 5Y0.39%
F-Score7
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 4.18
Debt/EBITDA 1.41
Cap/Depr 49.38%
Cap/Sales 5.69%
Interest Coverage 250
Cash Conversion 73.95%
Profit Quality 141.24%
Current Ratio 0.97
Quick Ratio 0.67
Altman-Z 4.62
F-Score7
WACC7.82%
ROIC/WACC0.69
Cap/Depr(3y)51.19%
Cap/Depr(5y)45.17%
Cap/Sales(3y)6.06%
Cap/Sales(5y)5.58%
Profit Quality(3y)145.59%
Profit Quality(5y)677.55%
High Growth Momentum
Growth
EPS 1Y (TTM)3%
EPS 3Y13.7%
EPS 5Y16.01%
EPS Q2Q%2.1%
EPS Next Y6.78%
EPS Next 2Y8.91%
EPS Next 3Y9.98%
EPS Next 5Y9.2%
Revenue 1Y (TTM)5.45%
Revenue growth 3Y10.18%
Revenue growth 5Y8.8%
Sales Q2Q%5.52%
Revenue Next Year4.62%
Revenue Next 2Y5.36%
Revenue Next 3Y5.93%
Revenue Next 5Y6.39%
EBIT growth 1Y6.6%
EBIT growth 3Y15.34%
EBIT growth 5Y15.84%
EBIT Next Year56.93%
EBIT Next 3Y22.99%
EBIT Next 5Y16.01%
FCF growth 1Y3.16%
FCF growth 3Y-1.57%
FCF growth 5Y6.95%
OCF growth 1Y2.06%
OCF growth 3Y2.36%
OCF growth 5Y8.12%

ESSILORLUXOTTICA / 1EL.MI FAQ

What is the fundamental rating for 1EL stock?

ChartMill assigns a fundamental rating of 4 / 10 to 1EL.MI.


What is the valuation status for 1EL stock?

ChartMill assigns a valuation rating of 2 / 10 to ESSILORLUXOTTICA (1EL.MI). This can be considered as Overvalued.


What is the profitability of 1EL stock?

ESSILORLUXOTTICA (1EL.MI) has a profitability rating of 6 / 10.


What is the valuation of ESSILORLUXOTTICA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ESSILORLUXOTTICA (1EL.MI) is 46.13 and the Price/Book (PB) ratio is 3.88.


What is the expected EPS growth for ESSILORLUXOTTICA (1EL.MI) stock?

The Earnings per Share (EPS) of ESSILORLUXOTTICA (1EL.MI) is expected to grow by 6.78% in the next year.